(−)-Cassine/(−)-Spectaline alkaloid mixture inhibits cell proliferation in hepatocellular carcinoma cell line.
Antiproliferative activity of (−)-cassine/(−)-spectaline alkaloids is associated to cell cycle arrest in G1/S transition.
(−)-Cassine/(−)-Spectaline alkaloids are effective in modulating cyclin D expression.
ERK activation is inhibited in HepG2 cells treated with (−)-cassine/(−)-spectaline alkaloids.